BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32103002)

  • 1. B38-CAP is a bacteria-derived ACE2-like enzyme that suppresses hypertension and cardiac dysfunction.
    Minato T; Nirasawa S; Sato T; Yamaguchi T; Hoshizaki M; Inagaki T; Nakahara K; Yoshihashi T; Ozawa R; Yokota S; Natsui M; Koyota S; Yoshiya T; Yoshizawa-Kumagaye K; Motoyama S; Gotoh T; Nakaoka Y; Penninger JM; Watanabe H; Imai Y; Takahashi S; Kuba K
    Nat Commun; 2020 Feb; 11(1):1058. PubMed ID: 32103002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2-like enzyme B38-CAP suppresses abdominal sepsis and severe acute lung injury.
    Minato T; Yamaguchi T; Hoshizaki M; Nirasawa S; An J; Takahashi S; Penninger JM; Imai Y; Kuba K
    PLoS One; 2022; 17(7):e0270920. PubMed ID: 35867642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE2-like carboxypeptidase B38-CAP protects from SARS-CoV-2-induced lung injury.
    Yamaguchi T; Hoshizaki M; Minato T; Nirasawa S; Asaka MN; Niiyama M; Imai M; Uda A; Chan JF; Takahashi S; An J; Saku A; Nukiwa R; Utsumi D; Kiso M; Yasuhara A; Poon VK; Chan CC; Fujino Y; Motoyama S; Nagata S; Penninger JM; Kamada H; Yuen KY; Kamitani W; Maeda K; Kawaoka Y; Yasutomi Y; Imai Y; Kuba K
    Nat Commun; 2021 Nov; 12(1):6791. PubMed ID: 34815389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II.
    Yamamoto K; Ohishi M; Katsuya T; Ito N; Ikushima M; Kaibe M; Tatara Y; Shiota A; Sugano S; Takeda S; Rakugi H; Ogihara T
    Hypertension; 2006 Apr; 47(4):718-26. PubMed ID: 16505206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candesartan ameliorates cardiac dysfunction observed in angiotensin-converting enzyme 2-deficient mice.
    Nakamura K; Koibuchi N; Nishimatsu H; Higashikuni Y; Hirata Y; Kugiyama K; Nagai R; Sata M
    Hypertens Res; 2008 Oct; 31(10):1953-61. PubMed ID: 19015603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex.
    Yang J; Feng X; Zhou Q; Cheng W; Shang C; Han P; Lin CH; Chen HS; Quertermous T; Chang CP
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5628-35. PubMed ID: 27601681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2.
    Liu P; Zhang Y; Li Z; Huang J; Wang T; Chen C
    Biochem Biophys Res Commun; 2022 May; 606():17-22. PubMed ID: 35338854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Apelin Augments Angiotensin II-Induced Cardiac Dysfunction and Pathological Remodeling.
    Sato T; Kadowaki A; Suzuki T; Ito H; Watanabe H; Imai Y; Kuba K
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
    Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
    Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
    Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
    Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
    J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats.
    Trask AJ; Averill DB; Ganten D; Chappell MC; Ferrario CM
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3019-24. PubMed ID: 17308000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ACE2-Fc chimeric fusion provides long-lasting hypertension control and organ protection in mouse models of systemic renin angiotensin system activation.
    Liu P; Wysocki J; Souma T; Ye M; Ramirez V; Zhou B; Wilsbacher LD; Quaggin SE; Batlle D; Jin J
    Kidney Int; 2018 Jul; 94(1):114-125. PubMed ID: 29691064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2 deficiency induced perivascular fibrosis and cardiac hypertrophy during postnatal development in mice.
    Moritani T; Iwai M; Kanno H; Nakaoka H; Iwanami J; Higaki T; Ishii E; Horiuchi M
    J Am Soc Hypertens; 2013; 7(4):259-66. PubMed ID: 23608725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent.
    Serfozo P; Wysocki J; Gulua G; Schulze A; Ye M; Liu P; Jin J; Bader M; Myöhänen T; García-Horsman JA; Batlle D
    Hypertension; 2020 Jan; 75(1):173-182. PubMed ID: 31786979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat.
    Dang Z; Su S; Jin G; Nan X; Ma L; Li Z; Lu D; Ge R
    J Ethnopharmacol; 2020 Mar; 250():112470. PubMed ID: 31862407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.